Antelope Dx logo — Antelope Dx creates a small diagnostic device for home use,...

Antelope Dx

Antelope Dx creates a small diagnostic device for home use, providing quick and accurate health testing.

Founded 2018 Belgium Belgium 11-50 employees Series B Total: $18.80M Biotechnology

General Information

Company Name Antelope Dx
Founded Year 2018
Location Belgium Belgium +1
Employees 11-50
Industries Biotechnology
Funding Stage Series B
Social

Get notified when Antelope Dx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Antelope Dx

Antelope Dx is a Belgium-based biotechnology startup that is revolutionizing home diagnostics with its flagship product—a compact, handheld medical testing tool. Founded in 2018, the company seeks to combine the accuracy of lab-grade diagnostics with the convenience and affordability of consumer-grade tests, akin to pregnancy kits.

Antelope Dx's device offers rapid and accessible health assessments, positioning itself as an invaluable tool for both individuals and healthcare providers. This innovation addresses a critical niche in the burgeoning remote and connected healthcare landscape.

The company secured a €9.00M Series B investment on 15 September 2020, showcasing confidence from investors like Saffelberg Investments, White Fund, and RMM. These funds aim to propel Antelope Dx's growth trajectory, facilitating further development and market penetration of its diagnostic platform.

Taxonomy: Home Diagnostics, Handheld Medical Devices, Rapid Health Testing, Consumer Health Technology, Lab-grade Testing Quality, Affordable Health Solutions, Innovative Diagnostic Platform, Health Monitoring, Medical Test Miniaturization, Non-invasive Testing, User-friendly Medical Devices

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 3
Investor Investor
•••• ••••
15 Sep 2020
Grant •••••• 1 •••• •••• 04 Aug 2020
Grant •••••• 1 •••• •••• 08 Jan 2020
Series A •••••• 2
Investor
•••• ••••
20 Aug 2019

Antelope Dx Alternatives & Competitors

Antelope Dx vs

Manufacturing and distributing high-quality rapid tests and in vitro diagnostic (IVD) devices.

17 employees
Health Care, Manufacturing
Antelope Dx vs

A leading provider in diagnostic, point of care medical devices. Dedicated to providing top notch se...

10 employees
Health Care
Antelope Dx vs

Doing it for the ladies and the environment

9 employees

FAQ About Antelope Dx

Antelope Dx creates a small diagnostic device for home use, providing quick and accurate health testing.
Antelope Dx was founded in 2018.
Antelope Dx is headquartered in Belgium.
Antelope Dx operates in the following industries: Biotechnology.
Antelope Dx has approximately 11-50 employees.
Antelope Dx has completed 4 funding rounds, raising a total of $18.80M. The latest funding stage is Series B.
Top alternatives and competitors to Antelope Dx include Verify Diagnostics, STAT-Technologies, Inc., ova&me by Pharmista Technologies, Egoo.Health, Viacentra. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Antelope Dx and Verify Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Antelope Dx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes